Mårten Segelmark
41 – 50 of 204
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Identification and Functional Characterization of a Novel Susceptibility Locus for Small Vessel Vasculitis with MPO-ANCA
- Contribution to journal › Article
-
Mark
Använd ekvationer utan »ras«- termer för att bestämma GFR
- Contribution to journal › Scientific review
-
Mark
Incidence of Kidney Replacement Therapy and Subsequent Outcomes Among Patients With Systemic Lupus Erythematosus : Findings From the ERA Registry
- Contribution to journal › Article
-
Mark
Authors' Reply : Endopeptidase Therapy for Anti-Glomerular Basement Membrane Disease: Beware of Anti-Hinge Antibodies!
- Contribution to journal › Letter
-
Mark
The management of membranous nephropathy—an update
- Contribution to journal › Article
-
Mark
Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases : consensus statements from the ERA-IWG and EUVAS
- Contribution to journal › Scientific review
-
Mark
The Sound of Interconnectivity; The European Vasculitis Society 2022 Report
- Contribution to journal › Article
-
Mark
Infection is associated with increased risk of MPO- but not PR3-ANCA associated vasculitis
- Contribution to journal › Article
-
Mark
Clustering of anti-neutrophil cytoplasmic antibody-associated vasculitis - using a pre-processed harmonised dataset
(2022) 20th International Vasculitis and ANCA workshop
- Contribution to conference › Abstract
-
Mark
Epidemiology and Clinical Characteristics of Adult-Onset IgA Vasculitis in Southern Sweden
(2022) 20th International Vasculitis and ANCA workshop
- Contribution to conference › Abstract
